Study Start Up Associate
ICON plc
Summary
As a Study Start Up Associate II at ICON, you will lead the initiation of clinical trials, ensuring compliance with regulatory requirements, and contribute to the advancement of innovative treatments and therapies.
Job description
What You Will Do:
- Establish, maintenance and archival of compound-related files and trial-related files as required per procedures
- Create and maintain clinical plan and compound information
- Partner closely with Clinical Trial Project Manager and Program Lead to deliver clinical trials
- Obtain or prepare relevant documentation necessary for a clinical trial based on GCP or Local regulations for Site Activation, Maintenance and Close-out (e.g. New Trial Statements for insurance certificates, copyright permissions and document translations, Clinical Trial Applications)
- Assist in the planning, forecasting, and tracking of trial budgets, POs and invoices
- Perform assessments of potential vendors and investigator sites for exploratory and biopharmaceutics clinical development studies
- Identify, communicate, and resolve issues
- Understand FRAP and consult with teams regarding FRAP compliance
- Populate internal systems to ensure accuracy of trial / site performance
- Understand and comply with procurements, legal and financial requirements and procedures
Your Profile:
Required qualifications and experience:
- Bachelor's Degree in a scientific or health-related field; or equivalent qualifications/experience (3 years pharmaceutical industry experience)
- Understanding of the overall clinical development paradigm and the importance of efficient site activation and maintenance
- Strong self-management, analytical and organizational skills
- Demonstrated problem-solving abilities
- Ability to prioritize and handle a high volume of activities
- Proficiency with business software packages
- Strong communication (verbal and written) skills and willingness to collaborate globally
- Applied knowledge of project management processes and skills
- Appreciation of / experience in compliance-driven environment
- Ability to learn and comply with financial and legal guidelines and policies (budget and contract)
Requirements
- Bachelor's Degree in a scientific or health-related field; or equivalent qualifications/experience (3 years pharmaceutical industry experience)
- Understanding of the overall clinical development paradigm and the importance of efficient site activation and maintenance
- Strong self-management, analytical and organizational skills
- Demonstrated problem-solving abilities
- Ability to prioritize and handle a high volume of activities
- Proficiency with business software packages
- Strong communication (verbal and written) skills and willingness to collaborate globally
- Applied knowledge of project management processes and skills
- Appreciation of / experience in compliance-driven environment
- Ability to learn and comply with financial and legal guidelines and policies (budget and contract)
Benefits
- Competitive base salary
- Performance incentives
- Medical, Dental & Vision
- Retirement & pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.